The Asia Pacific Rabies Vaccine Market would witness market growth of 5.1% CAGR during the forecast period (2023-2030).
The China market dominated the Asia Pacific Rabies Vaccine Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $118.8 Million by 2030. The Japan market is registering a CAGR of 4.3% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 5.7% during (2023 - 2030).
Urbanization and encroachment into wildlife habitats can increase interactions between humans, domestic animals, and wildlife, raising the risk of dog bites. As urban areas expand and human populations grow, the potential for encountering rabies-infected animals, particularly dogs, escalates. This trend amplifies the importance of vaccination efforts to curb the spread of rabies.
There is a growing recognition of the interconnectedness of human, animal, and environmental health. The One Health approach emphasizes collaborative efforts between human and veterinary healthcare professionals, environmental scientists, and other stakeholders to address rabies at the interface of wildlife, domestic animals, and humans. This holistic perspective enhances the effectiveness of rabies control strategies by considering the complex interactions between different ecosystems.
India has a high incidence of rabies cases, and the disease is a serious public health issue. Public health awareness campaigns are crucial in educating communities about the risks of rabies and the importance of vaccination in India. Rabies control initiatives are implemented in rural and urban areas, recognizing that rabies affects populations across diverse settings in India. The One Health approach, recognizing the interconnectedness of human, animal, and environmental health, is applied in rabies control efforts in India. As per a report published by the Ministry of Health and Family Welfare Government of India, dog-mediated rabies is responsible for an estimated 35172 human deaths (59.6% of global deaths) and 2.2 million disability-adjusted life years (DALYs) lost annually in Asia in 2022. Therefore, due to the above-mentioned factors, the market will grow significantly in this region.
Free Valuable Insights: The Global Rabies Vaccine Market is Predict to reach USD 1.6 Billion by 2030, at a CAGR of 4.5%
Based on Prophylaxis Type, the market is segmented into Post-exposure Prophylaxis, and Pre-exposure prophylaxis. Based on End User, the market is segmented into Hospitals, Veterinary Clinics, and Others. Based on Application, the market is segmented into Human, and Animal. Based on Product Type, the market is segmented into Chick Embryo Cells Rabies Vaccine, Human Diploid Cell Vaccine, Vero cell rabies vaccine, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
By Prophylaxis Type
By End User
By Application
By Product Type
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
